• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型促炎和抗炎脂肪细胞因子与急性冠状动脉综合征患者的关系。

Association Between Novel Pro- and Anti- Inflammatory Adipocytokines in Patients with Acute Coronary Syndrome.

机构信息

Department of Cardiology, 117914Chengde Medical University Affiliated Hospital, Chengde, Hebei, China.

Central Laboratory of Chengde Medical University Affiliated Hospital, Chengde, Hebei, China.

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221128021. doi: 10.1177/10760296221128021.

DOI:10.1177/10760296221128021
PMID:36128744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9500265/
Abstract

BACKGROUND AND AIMS

Novel pro- and anti-inflammatory adipocytokines affect inflammation, energy metabolism, and insulin signaling. However, their role in acute coronary syndrome (ACS) development is unclear. We evaluated the diagnostic and risk predictive value of such adipocytokines for ACS.

METHODS

We enrolled 168 consecutive inpatients with suspected ACS and detected serum PLIN1, PLIN2, PLIN5, CTRP6, CTRP7, CTRP11, WISP1, FAM19A5, TNF-α, and adiponectin levels. Multivariate logistic regression analysis and Spearman's test were used to assess risk factors for ACS and correlations between serum adipocytokines and continuous variables, respectively.

RESULTS

Serum levels of the adipocytokines differed between ACS and Non-ACS groups ( < 0.05). After adjusting for confounding factors, serum PLIN1, PLIN2, PLIN5, CTRP6, CTRP7, CTRP11, WISP1, and FAM19A5 levels were independently associated with ACS ( < 0.05). Increasing tertiles of serum PLIN1, PLIN2, CTRP7, CTRP11, and WISP1 levels increased the ACS risk, which decreased gradually with increasing PLIN5 and CTRP6 tertiles ( for trend <0.05). Serum PLIN1, PLIN5, CTRP6, CTRP7, CTRP11, WISP1, and FAM19A5 levels correlated with ACS severity.

CONCLUSIONS

PLIN1, PLIN2, CTRP7, CTRP11, and WISP1 were identified as independent ACS risk factors, whereas PLIN5, CTRP6, and FAM19A5 were independent protective factors for ACS. These serum adipocytokines are novel potential clinical biomarkers of ACS.

摘要

背景与目的

新型促炎和抗炎脂肪细胞因子影响炎症、能量代谢和胰岛素信号。然而,它们在急性冠状动脉综合征(ACS)发展中的作用尚不清楚。我们评估了这些脂肪细胞因子对 ACS 的诊断和风险预测价值。

方法

我们连续纳入 168 例疑似 ACS 的住院患者,检测血清 PLIN1、PLIN2、PLIN5、CTRP6、CTRP7、CTRP11、WISP1、FAM19A5、TNF-α 和脂联素水平。采用多变量逻辑回归分析和 Spearman 检验分别评估 ACS 的危险因素和血清脂肪细胞因子与连续变量之间的相关性。

结果

ACS 组和非 ACS 组的血清脂肪细胞因子水平不同( < 0.05)。在校正混杂因素后,血清 PLIN1、PLIN2、PLIN5、CTRP6、CTRP7、CTRP11、WISP1 和 FAM19A5 水平与 ACS 独立相关( < 0.05)。血清 PLIN1、PLIN2、CTRP7、CTRP11 和 WISP1 水平递增 tertile 增加 ACS 风险,而 PLIN5 和 CTRP6 水平递增 tertile 则逐渐降低 ACS 风险(趋势检验 < 0.05)。血清 PLIN1、PLIN5、CTRP6、CTRP7、CTRP11、WISP1 和 FAM19A5 水平与 ACS 严重程度相关。

结论

PLIN1、PLIN2、CTRP7、CTRP11 和 WISP1 被确定为 ACS 的独立危险因素,而 PLIN5、CTRP6 和 FAM19A5 是 ACS 的独立保护因素。这些血清脂肪细胞因子是 ACS 的潜在新型临床生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/9d8d99eee9d9/10.1177_10760296221128021-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/d8518082d531/10.1177_10760296221128021-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/b8ace2137200/10.1177_10760296221128021-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/9d8d99eee9d9/10.1177_10760296221128021-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/d8518082d531/10.1177_10760296221128021-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/b8ace2137200/10.1177_10760296221128021-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c9d/9500265/9d8d99eee9d9/10.1177_10760296221128021-fig3.jpg

相似文献

1
Association Between Novel Pro- and Anti- Inflammatory Adipocytokines in Patients with Acute Coronary Syndrome.新型促炎和抗炎脂肪细胞因子与急性冠状动脉综合征患者的关系。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221128021. doi: 10.1177/10760296221128021.
2
Role of serum C1q/TNF-related protein family levels in patients with acute coronary syndrome.血清C1q/TNF相关蛋白家族水平在急性冠状动脉综合征患者中的作用。
Front Cardiovasc Med. 2022 Aug 19;9:967918. doi: 10.3389/fcvm.2022.967918. eCollection 2022.
3
Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease.新型循环促炎和抗炎脂肪细胞因子与冠状动脉疾病之间的关联
Coron Artery Dis. 2019 Nov;30(7):528-535. doi: 10.1097/MCA.0000000000000778.
4
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis.血清脂联素水平可预测严重颈动脉狭窄患者的急性冠状动脉综合征(ACS)。
Vascul Pharmacol. 2018 Mar;102:37-43. doi: 10.1016/j.vph.2017.12.066. Epub 2018 Jan 2.
5
Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.接受肿瘤坏死因子-α抑制剂治疗的银屑病患者的血清脂肪细胞因子水平:一项回顾性分析结果
Int J Dermatol. 2015 Jul;54(7):839-45. doi: 10.1111/ijd.12706. Epub 2015 Apr 15.
6
Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris.趋化素是急性冠状动脉综合征的一种新型生物标志物,但不是稳定型心绞痛的生物标志物。
Cardiovasc Diabetol. 2014 Nov 1;13:145. doi: 10.1186/s12933-014-0145-4.
7
Circulating CTRP7 Is a Potential Predictor for Metabolic Syndrome.循环 CTRP7 是代谢综合征的潜在预测因子。
Front Endocrinol (Lausanne). 2021 Nov 11;12:774309. doi: 10.3389/fendo.2021.774309. eCollection 2021.
8
Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients.血清脂肪细胞因子水平与 2 型糖尿病患者心脏自主神经病变的关系。
Cardiovasc Diabetol. 2012 Mar 13;11:24. doi: 10.1186/1475-2840-11-24.
9
Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.C1q/TNF家族成员的分子、生化及功能特性:脂肪组织选择性表达模式、PPAR-γ激动剂的调控、半胱氨酸介导的寡聚化、组合性关联及代谢功能
Biochem J. 2008 Dec 1;416(2):161-77. doi: 10.1042/BJ20081240.
10
High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease.高血浆脂联素水平与冠心病患者血小板活化有关。
Platelets. 2010;21(1):11-9. doi: 10.3109/09537100903377584.

引用本文的文献

1
Plin5: A potential therapeutic target for type 2 diabetes mellitus.Plin5:2型糖尿病的一个潜在治疗靶点。
Diabetol Metab Syndr. 2025 Apr 2;17(1):114. doi: 10.1186/s13098-025-01680-1.
2
Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in coronary artery disease and its correlation with inflammatory markers.冠状动脉疾病中C1q/TNF-α相关蛋白6(CTRP6)的循环水平及其与炎症标志物的相关性。
J Diabetes Metab Disord. 2024 Apr 17;23(1):1233-1241. doi: 10.1007/s40200-024-01415-5. eCollection 2024 Jun.
3
Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

本文引用的文献

1
CTRP11 contributes modestly to systemic metabolism and energy balance.CTRP11 对全身代谢和能量平衡的贡献较小。
FASEB J. 2022 Jun;36(6):e22347. doi: 10.1096/fj.202200189RR.
2
CTRP7 Is a Biomarker Related to Insulin Resistance and Oxidative Stress: Cross-Sectional and Intervention Studies In and In .CTRP7 是与胰岛素抵抗和氧化应激相关的生物标志物:横断面和干预研究在 和 中。
Oxid Med Cell Longev. 2022 Mar 23;2022:6877609. doi: 10.1155/2022/6877609. eCollection 2022.
3
Acute coronary syndromes.急性冠状动脉综合征。
脂肪因子FAM19A5能否作为代谢紊乱的生物标志物?
Diabetes Metab Syndr Obes. 2024 Apr 10;17:1651-1666. doi: 10.2147/DMSO.S460226. eCollection 2024.
4
CCN3/NOV serum levels in coronary artery disease (CAD) patients and its correlation with TNF-α and IL-6.冠心病患者血清中 CCN3/NOV 水平及其与 TNF-α 和 IL-6 的相关性。
BMC Res Notes. 2023 Nov 2;16(1):306. doi: 10.1186/s13104-023-06590-x.
5
Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer.干预 perilipins(PLINs)以调节肥胖和癌症中脂滴动态的药理学挑战。
Cancers (Basel). 2023 Aug 7;15(15):4013. doi: 10.3390/cancers15154013.
Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6.
4
Perilipins at a glance.脂肪滴包被蛋白概述。
J Cell Sci. 2022 Mar 1;135(5). doi: 10.1242/jcs.259501. Epub 2022 Mar 9.
5
Reassessing Human Adipose Tissue.重新评估人体脂肪组织。
N Engl J Med. 2022 Feb 24;386(8):768-779. doi: 10.1056/NEJMra2032804.
6
Adipose-tissue plasticity in health and disease.健康与疾病中的脂肪组织可塑性。
Cell. 2022 Feb 3;185(3):419-446. doi: 10.1016/j.cell.2021.12.016.
7
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
8
Inflammation in obesity, diabetes, and related disorders.肥胖、糖尿病及相关紊乱中的炎症。
Immunity. 2022 Jan 11;55(1):31-55. doi: 10.1016/j.immuni.2021.12.013.
9
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease.心外膜脂肪细胞衍生的 TNF-α 调节晚期冠状动脉疾病患者的局部炎症。
Curr Vasc Pharmacol. 2022;20(1):87-93. doi: 10.2174/1570161119666211029110813.
10
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.